Description and Brand Names
Drug information provided by: IBM Micromedex
US Brand Name
Pomalidomide is used in combination with dexamethasone to treat multiple myeloma (cancer of the blood) in patients who have received at least 2 other medicines that did not work well. This medicine is used in patients with multiple myeloma that has worsened during treatment or within 60 days of the last treatment. It interferes with the growth of multiple myeloma cells, which are eventually destroyed in the body. Pomalidomide is an antineoplastic (cancer medicine).
This medicine is available only under a restricted distribution program called the Pomalyst® REMS (Risk Evaluation and Mitigation Strategy) program.
This product is available in the following dosage forms: